Save $$$ on Metoclopramide purchased online

Business Editors & High Tech Writers
HAYWARD, Calif.–(BUSINESS WIRE)–Oct. 19, 2000
Questcor Pharmaceuticals Inc. (AMEX:QSC) announced today the results of the Phase II study of Emitasol(R) (Metoclopramide, Nasal Spray) in the treatment of diabetic gastroparesis, a serious complication of diabetes that substantially reduces quality of life. The study found encouraging results in terms of safety and a preliminary evaluation of efficacy.
In this open-label, multic…

A daily dose of metoclopramide decreased tic severity by 38.7% in children aged 7-18 years with Tourette’s disorder, compared with a 12.6% reduction in a placebo group, reported Rob Nicholson, M.D., of the University of Western Ontario in London, and his colleagues.
In a randomized, double-blind, placebo-controlled study of 27 children, 14 received metoclopramide starting at…

DENVER — The dopamine receptor antagonist metoclopramide shows potential as a tic suppressant in patients with Tourette’s syndrome according to a small preliminary study, Dr. Maria T. Acosta reported at the annual meet…